Assessment of new tablet formulation of deferasirox to decrease persistent iron overload after long-term blood transfusions
Received Date: Aug 16, 2021 / Accepted Date: Aug 23, 2021 / Published Date: Aug 30, 2021
Citation: Zhang X (2021) Assessment of New Tablet Formulation of Deferasirox to Decrease Persistent Iron Overload after Long-Term Blood Transfusions. Clin Pharmacol Biopharm, 10: e120. Doi: 10.4172/2167-065X.1000e120
Copyright: © 2021 Zhang X. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Share This Article
Recommended Journals
Open Access Journals
Article Tools
Article Usage
- Total views: 1665
- [From(publication date): 0-2021 - Jan 31, 2025]
- Breakdown by view type
- HTML page views: 1189
- PDF downloads: 476